David Low
Stock Analyst at UBS
(3.03)
# 2,627
Out of 4,600 analysts
295
Total ratings
49.2%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Maintained: Buy | $158.00 | $129.69 | +21.83% | 30 | Jul 31, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $106.00 | $121.05 | -12.43% | 21 | Jul 15, 2026 | |
| ASX: REG Regis Healthcare Limited | Maintained: Hold | $8.00 → $7.00 | $6.36 | +10.06% | 14 | Jul 8, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $35.60 → $34.25 | $34.22 | +0.09% | 16 | Jul 6, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $19.60 | $22.16 | -11.55% | 32 | Jul 1, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $42.90 | $43.60 | -1.61% | 20 | May 28, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | n/a | $31.54 | - | 24 | Apr 28, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Downgraded: Hold | $16.50 | $14.71 | +12.21% | 3 | Aug 31, 2025 | |
| ASX: PNV PolyNovo Limited | Maintained: Hold | $1.30 | $0.87 | +50.29% | 1 | Aug 27, 2025 | |
| NZE: EBO EBOS Group Limited | Maintained: Hold | $46.03 → $43.64 | $22.00 | +98.36% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4.00 → $3.90 | $3.48 | +12.07% | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.25 → $3.40 | $2.22 | +53.50% | 12 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.62 | $0.41 | +52.33% | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $282.00 → $300.00 | $179.74 | +66.91% | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $290 → $310 | $223.14 | n/a | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 32.00 → 35.00 | 42.69 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.95 → $0.78 | $0.29 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.49 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $22.97 | n/a | 1 | Dec 4, 2019 |
CSL Limited
Jul 31, 2026
Maintained: Buy
Price Target: $158.00
Current: $129.69
Upside: +21.83%
Cochlear Limited
Jul 15, 2026
Maintained: Hold
Price Target: $106.00
Current: $121.05
Upside: -12.43%
Regis Healthcare Limited
Jul 8, 2026
Maintained: Hold
Price Target: $8.00 → $7.00
Current: $6.36
Upside: +10.06%
Ansell Limited
Jul 6, 2026
Maintained: Hold
Price Target: $35.60 → $34.25
Current: $34.22
Upside: +0.09%
Sonic Healthcare Limited
Jul 1, 2026
Maintained: Hold
Price Target: $19.60
Current: $22.16
Upside: -11.55%
Ramsay Health Care Limited
May 28, 2026
Maintained: Hold
Price Target: $42.90
Current: $43.60
Upside: -1.61%
ResMed Inc.
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $31.54
Upside: -
Telix Pharmaceuticals Limited
Aug 31, 2025
Downgraded: Hold
Price Target: $16.50
Current: $14.71
Upside: +12.21%
PolyNovo Limited
Aug 27, 2025
Maintained: Hold
Price Target: $1.30
Current: $0.87
Upside: +50.29%
EBOS Group Limited
Aug 27, 2025
Maintained: Hold
Price Target: $46.03 → $43.64
Current: $22.00
Upside: +98.36%
Aug 27, 2025
Maintained: Sell
Price Target: $4.00 → $3.90
Current: $3.48
Upside: +12.07%
Aug 27, 2025
Maintained: Buy
Price Target: $3.25 → $3.40
Current: $2.22
Upside: +53.50%
Aug 25, 2025
Maintained: Sell
Price Target: $0.62
Current: $0.41
Upside: +52.33%
Aug 14, 2025
Maintained: Hold
Price Target: $282.00 → $300.00
Current: $179.74
Upside: +66.91%
Aug 1, 2025
Maintained: Buy
Price Target: $290 → $310
Current: $223.14
Upside: n/a
Jun 3, 2025
Maintained: Hold
Price Target: 32.00 → 35.00
Current: 42.69
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $0.95 → $0.78
Current: $0.29
Upside: n/a
Aug 23, 2021
Maintained: Hold
Price Target: n/a
Current: $15.49
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $22.97
Upside: n/a